KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Total Liabilities (2020 - 2025)

Organon has reported Total Liabilities over the past 6 years, most recently at $12.1 billion for Q4 2025.

  • Quarterly results put Total Liabilities at $12.1 billion for Q4 2025, down 4.07% from a year ago — trailing twelve months through Dec 2025 was $12.1 billion (down 4.07% YoY), and the annual figure for FY2025 was $12.1 billion, down 4.07%.
  • Total Liabilities for Q4 2025 was $12.1 billion at Organon, down from $12.6 billion in the prior quarter.
  • Over the last five years, Total Liabilities for OGN hit a ceiling of $13.0 billion in Q3 2021 and a floor of $4.9 billion in Q1 2021.
  • Median Total Liabilities over the past 5 years was $12.1 billion (2024), compared with a mean of $11.8 billion.
  • Biggest five-year swings in Total Liabilities: surged 283.33% in 2021 and later decreased 11.19% in 2022.
  • Organon's Total Liabilities stood at $12.2 billion in 2021, then dropped by 2.81% to $11.8 billion in 2022, then increased by 2.37% to $12.1 billion in 2023, then rose by 4.13% to $12.6 billion in 2024, then fell by 4.07% to $12.1 billion in 2025.
  • The last three reported values for Total Liabilities were $12.1 billion (Q4 2025), $12.6 billion (Q3 2025), and $12.8 billion (Q2 2025) per Business Quant data.